| Association of facial paralysis with mRNA COVID-19 vaccines: a disproportionality analysis using the World Health Organization pharmacovigilance database L Renoud, C Khouri, B Revol, M Lepelley, J Perez, M Roustit, ... JAMA Internal Medicine 181 (9), 1243-1245, 2021 | 110 | 2021 |
| SGLT‐2 inhibitors and the risk of lower‐limb amputation: is this a class effect? C Khouri, JL Cracowski, M Roustit Diabetes, Obesity and Metabolism 20 (6), 1531-1534, 2018 | 99 | 2018 |
| The French health pass holds lessons for mandatory COVID-19 vaccination JK Ward, F Gauna, A Gagneux-Brunon, E Botelho-Nevers, JL Cracowski, ... Nature Medicine 28 (2), 232-235, 2022 | 94 | 2022 |
| Drug‐induced Raynaud's phenomenon: beyond β‐adrenoceptor blockers C Khouri, S Blaise, P Carpentier, C Villier, JL Cracowski, M Roustit British journal of clinical pharmacology 82 (1), 6-16, 2016 | 73 | 2016 |
| Targeting the prostacyclin pathway: beyond pulmonary arterial hypertension H Pluchart, C Khouri, S Blaise, M Roustit, JL Cracowski Trends in Pharmacological Sciences 38 (6), 512-523, 2017 | 65 | 2017 |
| Hierarchical evaluation of electrical stimulation protocols for chronic wound healing: an effect size meta‐analysis C Khouri, S Kotzki, M Roustit, S Blaise, F Gueyffier, JL Cracowski Wound Repair and Regeneration 25 (5), 883-891, 2017 | 60 | 2017 |
| Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases C Khouri, C Petit, M Tod, M Lepelley, B Revol, M Roustit, JL Cracowski Journal of Clinical Epidemiology 134, 14-21, 2021 | 51 | 2021 |
| Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance–pharmacodynamic study L Cornet, C Khouri, M Roustit, C Guignabert, MC Chaumais, M Humbert, ... European Respiratory Journal 53 (5), 2019 | 48 | 2019 |
| On-Demand Sildenafil as a Treatment for Raynaud Phenomenon: A Series of n-of-1 Trials M Roustit, J Giai, O Gaget, C Khouri, M Mouhib, A Lotito, S Blaise, ... Annals of Internal Medicine 169 (10), 694-703, 2018 | 43 | 2018 |
| Peripheral vasoconstriction induced by β‐adrenoceptor blockers: a systematic review and a network meta‐analysis C Khouri, T Jouve, S Blaise, P Carpentier, JL Cracowski, M Roustit British journal of clinical pharmacology 82 (2), 549-560, 2016 | 34 | 2016 |
| Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID‐19 pandemic L Larrouquere, M Gabin, E Poingt, A Mouffak, A Hlavaty, M Lepelley, ... Fundamental & Clinical Pharmacology 34 (3), 389-396, 2020 | 33 | 2020 |
| Reported adverse drug reactions associated with the use of hydroxychloroquine and chloroquine during the COVID-19 pandemic J Perez, M Roustit, M Lepelley, B Revol, JL Cracowski, C Khouri Annals of Internal Medicine 174 (6), 878-880, 2021 | 30 | 2021 |
| Comparative efficacy and safety of treatments for secondary Raynaud's phenomenon: a systematic review and network meta-analysis of randomised trials C Khouri, M Lepelley, S Bailly, S Blaise, AL Herrick, M Matucci-Cerinic, ... The Lancet Rheumatology 1 (4), e237-e246, 2019 | 30 | 2019 |
| Intermittent hypoxia-related alterations in vascular structure and function: a systematic review and meta-analysis of rodent data O Harki, Q Boete, JL Pépin, C Arnaud, E Belaidi, G Faury, C Khouri, ... European Respiratory Journal 59 (3), 2022 | 26 | 2022 |
| The continuums of impairment in vascular reactivity across the spectrum of cardiometabolic health: a systematic review and network meta‐analysis J Loader, C Khouri, F Taylor, S Stewart, C Lorenzen, JL Cracowski, ... Obesity reviews 20 (6), 906-920, 2019 | 26 | 2019 |
| Comparative safety of drugs targeting the nitric oxide pathway in pulmonary hypertension: a mixed approach combining a meta-analysis of clinical trials and a disproportionality … C Khouri, M Lepelley, M Roustit, F Montastruc, M Humbert, JL Cracowski Chest 154 (1), 136-147, 2018 | 26 | 2018 |
| Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents E Belaidi, C Khouri, O Harki, S Baillieul, G Faury, A Briançon-Marjollet, ... European Respiratory Review 31 (164), 2022 | 25 | 2022 |
| Leveraging the variability of pharmacovigilance disproportionality analyses to improve signal detection performances C Khouri, T Nguyen, B Revol, M Lepelley, A Pariente, M Roustit, ... Frontiers in Pharmacology 12, 668765, 2021 | 23 | 2021 |
| The opioid epidemic: A worldwide exploratory study using the WHO pharmacovigilance database M Robert, E Jouanjus, C Khouri, N Fouilhé Sam‐Laï, B Revol Addiction 118 (4), 771-775, 2023 | 22 | 2023 |
| High prevalence of spin was found in pharmacovigilance studies using disproportionality analyses to detect safety signals: a meta-epidemiological study A Mouffak, M Lepelley, B Revol, C Bernardeau, F Salvo, A Pariente, ... Journal of Clinical Epidemiology 138, 73-79, 2021 | 21 | 2021 |
